Similar articles

• Colorectal cancer screening with fecal occult blood testing (FOBT): an international perspective.

  Achkar E, Moayyedi P. Achkar E, et al. Am J Gastroenterol. 2006 Feb;101(2):212. doi: 10.1111/j.1572-0241.2006.00484.x. Am J Gastroenterol. 2006. PMID: 16454818 No abstract available.
• The place of fecal occult blood test in colorectal cancer screening in 2006: the U.S. perspective.

  Bond JH. Bond JH. Am J Gastroenterol. 2006 Feb;101(2):219-21. doi: 10.1111/j.1572-0241.2006.00486.x. Am J Gastroenterol. 2006. PMID: 16454821 No abstract available.
• Does fecal occult blood test have a place for colorectal cancer screening in China in 2006?

  Sung J. Sung J. Am J Gastroenterol. 2006 Feb;101(2):213-5. doi: 10.1111/j.1572-0241.2006.00485.x. Am J Gastroenterol. 2006. PMID: 16454819 No abstract available.
• [Faecal occult blood test and mass screening for colorectal cancer].

  Hiwatashi N, Shimada T. Hiwatashi N, et al. Nihon Rinsho. 2003 Sep;61 Suppl 7:201-6. Nihon Rinsho. 2003. PMID: 14574882 Review. Japanese. No abstract available.
• Flexible sigmoidoscopy versus fecal occult blood testing for colorectal cancer screening in asymptomatic individuals.

  Stern C. Stern C. Clin J Oncol Nurs. 2014 Aug;18(4):471-2. doi: 10.1188/14.CJON.471-472. Clin J Oncol Nurs. 2014. PMID: 25095304 Review.